Intrinsic Value of S&P & Nasdaq Contact Us

ProQR Therapeutics N.V. PRQR NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • NL • USD

SharesGrow Score
57/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$3.63
+82.4%

Stock Statistics — PRQR

ProQR Therapeutics N.V. (PRQR) has a market capitalization of $209.67M and trades at $1.99. The 52-week range is 1.07-3.1.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -5.2, Earnings Per Share (EPS) of $-0.38, annual revenue of $15.28M.

The stock has a beta of 0.09, operates in the Healthcare sector.

Trading Data
Current Price$1.99
52-Week Range1.07-3.1
Volume456.49K
Avg Volume (30D)441.16K
Market Cap$209.67M
Beta (1Y)0.09
Company
IPO Date2014-09-18
Employees166
CEODaniel Anton de Boer
CountryNL
ExchangeNASDAQ Global Market
CurrencyUSD
ISINNL0010872495
CUSIPN71542109
Income (Latest Year)
Revenue$15.28M
Gross Profit$12.68M
EBITDA$-39.56M
Operating Income$-42.15M
Net Income$-40.52M
EPS$-0.38
EPS Diluted$-0.38
Shares Outstanding$105.33M
Balance Sheet (Latest Year)
Total Assets$112.71M
Current Assets$100.08M
Cash & ST Investments$92.37M
Total Liabilities$63.36M
Total Debt$13.99M
Net Debt$-78.39M
Total Equity$49.35M
Debt / Equity0.28
Valuation Ratios
P/E Ratio-5.2
P/S Ratio13.72
P/B Ratio4.25
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message